The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
PHQ‐9: global uptake of a depression scale
Open accessAbstract
Depression is the most prevalent mental disorder, a greater cause of disability than any other disease, and a major contributor to direct and indirect health care costs1. In the absence of a laboratory or imaging test, eliciting patient symptoms by clinical interview or a self-report scale is the principal way to detect depression and monitor its response to treatment. First published in 2001, the Patient Health Questionnaire 9-item depression scale (PHQ-9) has had global dissemination, with over 11,000 scientific citations and translations into more than 100 languages. It has been used in hundreds of clinical and population-based studies, incorporated into numerous depression guidelines, and implemented in many clinical practice settings. Depression screening is far from universal; however, where it occurs, the PHQ-9 is a leading scale2. The international spread of the PHQ-9 is likely due to multiple factors3. Its nine items comprise the DSM criteria for depressive disorders, making it both a severity and potentially diagnostic measure. The total score is a simple summation of item scores, and cut-points are easy to memorize: 5, 10, 15, and 20 represent thresholds for mild, moderate, moderately severe, and severe depressive symptoms, respectively. Unlike some depression scales, the PHQ-9 is free to use as a public domain measure, and the many translations make it accessible to populations around the world. The PHQ family includes several abbreviated versions and companion scales4. The PHQ-2 is an ultra-brief screener that comprises the first two items (depressed mood and anhedonia), which are core criteria for depressive disorders. The PHQ-8 omits the ninth item that asks about thoughts of "being better off dead or of hurting yourself in some way". Although conventionally considered a screening question for suicidal ideation, most positive responses represent endorsement of the first part of this compound item (i.e., being better off dead) rather than active thoughts of self-harm5, 6. Because the ninth item is the least frequently endorsed one, PHQ-8 and PHQ-9 scores are nearly identical, as are severity cut-points7. The PHQ-8 is sometimes used in studies where depression is a secondary outcome and not the focus of the investigation, in population-based studies where interviews are administered by non-mental health professionals, or in clinical settings where patient-reported outcomes (PROs) are captured outside of an office visit, causing delays in clarifying positive responses to the ninth item. Companion scales evaluate common fellow travelers of depression. The P4 is a 4-item measure that evaluates suicidal ideation in individuals who endorse the ninth item of the PHQ-96. The Generalized Anxiety Disorder 7-item (GAD-7) measures anxiety symptoms that co-occur in a third to half of patients with depression. Although initially developed for generalized anxiety disorder, the GAD-7 is also an effective screener for panic, social anxiety, and post-traumatic stress disorders4. The PHQ-15 and its abbreviated version (the Somatic Symptom Scale-8, SSS-8) assess the presence and severity of physical symptoms that are the complaints with which depressed patients most frequently present, and may denote concurrent somatic symptom disorder and other somatizing conditions8. Finally, the PHQ-4 consists of the PHQ-2 and the GAD-2 (abbreviated version of the GAD-7) and serves as an ultra-brief screener for depression and anxiety as well as general psychological distress. The PHQ family of scales, including many translations, are available at www.phqscreeners.com. Practical issues still constrain use of depression and other PRO measures in some clinical settings. Routine administration by the clinician or ancillary staff and manual entry of scores into the health records require time that is typically unreimbursed. The PHQ-9 and other PROs generally do not require an interview but rather can be self-administered using a variety of modes (e.g., paper or web-based forms, iPads, apps) before an office visit or while at home. Completed PROs can then be electronically imported or scanned into the records. Whereas universal depression screening is advocated by some guidelines, the optimal frequency of screening is not established. One approach is to screen all new patients and then annually in established patients. Because screening every patient at every visit is excessive, reminders of when screening is due are required. Another key role of depression measures is to monitor outcomes in response to active treatment of depression or, in some cases, watchful waiting. Again, flagging which patients require follow-up PHQ-9 administration must be operationalized. One critique of scales like the PHQ-9 is that depression is not simply a number. Certainly, a depression score alone should not generate a reflexive depression diagnosis or antidepressant prescription, but requires clinical evaluation to determine if the threshold for clin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
Self-citationWu, Y., Levis, B., Riehm, K. E., Saadat, N., Levis, A. W., Azar, M., Rice, D. B., Boruff, J., Cuijpers, P., Gilbody, S., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291719001314 · Cited by 423
Kroenke, K., & Unutzer, J. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3967-9 · Cited by 231
Self-citationSimon, G. E., Coleman, K. J., Rossom, R. C., Beck, A., Oliver, M., Johnson, E., Whiteside, U., Operskalski, B., Penfold, R. B., Shortreed, S. M., et al. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m09776 · Cited by 194
Dube, P., Kroenke, K., Bair, M. J., Theobald, D., & Williams, L. S. (2010) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.10m00978blu · Cited by 131
Self-citation
Cited by
Wang, L., Kroenke, K., Stump, T. E., & Monahan, P. O. (2021) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.12.007 · Cited by 153
Self-citationPersonal, social and relational predictors of UK postgraduate researcher mental health problems
Berry, C., Niven, J. E., & Hazell, C. M. (2021) · BJPsych Open · doi:10.1192/bjo.2021.1041 · Cited by 32
Risky drinking and cognitive impairment in community residents aged 50 and over
Rao, R., Creese, B., Aarsland, D., Kalafatis, C., Khan, Z., Corbett, A., & Ballard, C. (2022) · Aging & Mental Health · doi:10.1080/13607863.2021.2000938 · Cited by 14
Shea, S., Lionis, C., Kite, C., Atkinson, L., Chaggar, S. S., Randeva, H. S., & Kyrou, I. (2021) · Biomedicines · doi:10.3390/biomedicines9111697 · Cited by 4
Tang, Y., Gierc, M., La, H., Liu, S., Lam, R. W., Puterman, E., & Faulkner, G. (2025) · PLOS One · doi:10.1371/journal.pone.0321958 · Cited by 2
Metadata
- Authors
- Kroenke, K.
- Venue
- World Psychiatry
- Publisher
- Wiley
- Published
- 2021-01-12
- Volume
- 20
- Issue
- 1
- Pages
- 135-136
- ISSN
- 1723-8617 (ISSN-L)
- 2051-5545
- OpenAlex
- W3120577633
- Cited by
- 185
- References
- 5
- FWCI
- 22.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PHQ‐9: global uptake of a depression scale. https://app.cochat.ai/papers/10.1002/wps.20821
- The paper
- Kroenke, K. (2021). PHQ‐9: global uptake of a depression scale. World Psychiatry. https://doi.org/10.1002/wps.20821
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.